Related Experiment Video
Updated: Mar 28, 2026

Stability and Structure of Bat Major Histocompatibility Complex Class I with Heterologous β2-Microglobulin
Published on: March 10, 2021
Structure and stabilization of the Hendra virus F glycoprotein in its prefusion form
Joyce J W Wong1, Reay G Paterson2, Robert A Lamb3
1Department of Structural Biology, Stanford University School of Medicine, Stanford, CA 94305;
Abstract:
Hendra virus (HeV) is one of the two prototypical members of the Henipavirus genus of paramyxoviruses, which are designated biosafety level 4 (BSL-4) organisms due to the high mortality rate of Nipah virus (NiV) and HeV in humans. Paramyxovirus cell entry is mediated by the fusion protein, F, in response to binding of a host receptor by the attachment protein. During posttranslational processing, the fusion peptide of F is released and, upon receptor-induced triggering, inserts into the host cell membrane. As F undergoes a dramatic refolding from its prefusion to postfusion conformation, the fusion peptide brings the host and viral membranes together, allowing entry of the viral RNA. Here, we present the crystal structure of the prefusion form of the HeV F ectodomain. The structure shows very high similarity to the structure of prefusion parainfluenza virus 5 (PIV5) F, with the main structural differences in the membrane distal apical loops and the fusion peptide cleavage loop. Functional assays of mutants show that the apical loop can tolerate perturbation in length and surface residues without loss of function, except for residues involved in the stability and conservation of the F protein fold. Structure-based disulfide mutants were designed to anchor the fusion peptide to conformationally invariant residues of the F head. Two mutants were identified that inhibit F-mediated fusion by stabilizing F in its prefusion conformation.
Insights
Hendra virus (HeV) fusion protein structure reveals insights into paramyxovirus entry. Stabilizing the prefusion conformation inhibits viral fusion, offering potential therapeutic targets.
Area of Science:
- Structural biology
- Virology
- Molecular biology
Background:
- Hendra virus (HeV) is a Biosafety Level 4 (BSL-4) paramyxovirus with high human mortality.
- Paramyxovirus entry relies on the fusion (F) protein, which mediates viral and host cell membrane fusion.
- The F protein undergoes conformational changes from prefusion to postfusion states to facilitate viral entry.
Purpose of the Study:
- To determine the crystal structure of the Hendra virus fusion (F) protein in its prefusion conformation.
- To investigate the structural similarities and differences between HeV F and other paramyxovirus F proteins.
- To identify key regions and residues involved in F protein function and conformational stability.
Main Methods:
- X-ray crystallography to determine the prefusion structure of the HeV F ectodomain.
- Site-directed mutagenesis to create functional assays for F protein mutants.
- Disulfide bond engineering to stabilize specific F protein conformations.
Main Results:
- The crystal structure of the prefusion HeV F ectodomain was determined, showing high similarity to parainfluenza virus 5 (PIV5) F.
- Structural differences were noted in membrane-distal apical loops and the fusion peptide cleavage loop.
- Functional assays indicated that apical loop perturbations are tolerated, except for residues critical for fold stability.
- Structure-based disulfide mutants successfully stabilized the F protein in its prefusion conformation, inhibiting fusion.
Conclusions:
- The prefusion structure of HeV F provides a detailed molecular understanding of paramyxovirus entry mechanisms.
- Stabilizing the F protein in its prefusion state effectively inhibits viral fusion.
- Targeting the prefusion conformation of the HeV F protein represents a potential strategy for antiviral therapies against henipaviruses.
More Related Videos
09:12Surface Functionalization of Hepatitis E Virus Nanoparticles Using Chemical Conjugation Methods
Published on: May 11, 2018
08:10Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses
Published on: January 15, 2020